These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 38477525)

  • 41. Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.
    Cindil E; Sendur HN; Cerit MN; Erdogan N; Celebi F; Dag N; Celtikci E; Inan A; Oner Y; Tali T
    Acad Radiol; 2022 Mar; 29 Suppl 3():S52-S62. PubMed ID: 33685792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.
    Santo G; Laudicella R; Linguanti F; Nappi AG; Abenavoli E; Vergura V; Rubini G; Sciagrà R; Arnone G; Schillaci O; Minutoli F; Baldari S; Quartuccio N; Bisdas S
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multidisciplinary management of adult low grade gliomas.
    Mariş D; Nica D; Mohan D; Moisa H; Ciurea AV
    Chirurgia (Bucur); 2014; 109(5):590-9. PubMed ID: 25375042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
    Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
    Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Use of
    van de Weijer T; Broen MPG; Moonen RPM; Hoeben A; Anten M; Hovinga K; Compter I; van der Pol JAJ; Mitea C; Lodewick TM; Jacquerie A; Mottaghy FM; Wildberger JE; Postma AA
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging Methods in Nonenhancing Gliomas.
    Alkanhal H; Das K; Poptani H
    World Neurosurg; 2020 Sep; 141():123-130. PubMed ID: 32525092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-grade glioma management and response assessment-recent advances and current challenges.
    Khan MN; Sharma AM; Pitz M; Loewen SK; Quon H; Poulin A; Essig M
    Curr Oncol; 2016 Aug; 23(4):e383-91. PubMed ID: 27536188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas.
    Suh CH; Kim HS; Park JE; Jung SC; Choi CG; Woo DC; Lee HB; Kim SJ
    Radiol Imaging Cancer; 2020 Jul; 2(4):e190083. PubMed ID: 33778723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updates and Ongoing Challenges in Imaging of Multiple Myeloma:
    Wu F; Bernard S; Fayad LM; Ilaslan H; Messiou C; Moulopoulos LA; Mulligan ME
    AJR Am J Roentgenol; 2021 Oct; 217(4):775-785. PubMed ID: 33978464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.
    Li AY; Iv M
    Front Radiol; 2022; 2():883293. PubMed ID: 37492665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. State of the art in the diagnostic evaluation of osteomyelitis: exploring the role of advanced MRI sequences-a narrative review.
    Perera Molligoda Arachchige AS; Verma Y
    Quant Imaging Med Surg; 2024 Jan; 14(1):1070-1085. PubMed ID: 38223108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of Advanced MR Imaging Techniques and the Evolving Role of PET/MR Imaging in Neuro-oncology.
    Kwee TC; Donswijk ML
    PET Clin; 2013 Apr; 8(2):183-99. PubMed ID: 27157947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI.
    de Godoy LL; Lim KC; Rajan A; Verma G; Hanaoka M; O'Rourke DM; Lee JYK; Desai A; Chawla S; Mohan S
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?
    Hiremath SB; Muraleedharan A; Kumar S; Nagesh C; Kesavadas C; Abraham M; Kapilamoorthy TR; Thomas B
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):685-690. PubMed ID: 28209583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.
    Law M; Hamburger M; Johnson G; Inglese M; Londono A; Golfinos J; Zagzag D; Knopp EA
    Technol Cancer Res Treat; 2004 Dec; 3(6):557-65. PubMed ID: 15560713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.
    Vöglein J; Tüttenberg J; Weimer M; Gerigk L; Kauczor HU; Essig M; Weber MA
    Invest Radiol; 2011 Jun; 46(6):390-400. PubMed ID: 21285888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.